Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AMPX NYSEARCA:IWC NYSE:LODE NASDAQ:MRNS NYSEARCA:SPY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMPXAmprius Technologies$8.40+3.3%$7.44$0.81▼$9.66$1.02B2.725.79 million shs8.73 million shsIWCiShares Micro-Cap ETF$146.78+0.7%$137.15$95.25▼$147.13$939.39M1.1242,472 shs14,986 shsLODEComstock$2.87-1.4%$2.98$1.67▼$10.10$103.12M1.5633,285 shs1.09 million shsMRNSMarinus Pharmaceuticals$0.55-0.2%$0.55$0.22▼$1.97$30.32M1.031.94 million shs260 shsSPYSPDR S&P 500 ETF Trust$660.91+0.5%$638.01$481.80▼$661.04$685.35B169.26 million shs63.60 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMPXAmprius Technologies0.00%+14.19%+14.60%+97.37%+810.44%IWCiShares Micro-Cap ETF0.00%+1.64%+6.29%+17.43%+18.52%LODEComstock0.00%+22.27%+24.89%-27.07%-8.63%MRNSMarinus Pharmaceuticals0.00%0.00%0.00%0.00%-63.39%SPYSPDR S&P 500 ETF Trust0.00%+1.57%+2.17%+9.08%+16.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMPXAmprius Technologies$8.40+3.3%$7.44$0.81▼$9.66$1.02B2.725.79 million shs8.73 million shsIWCiShares Micro-Cap ETF$146.78+0.7%$137.15$95.25▼$147.13$939.39M1.1242,472 shs14,986 shsLODEComstock$2.87-1.4%$2.98$1.67▼$10.10$103.12M1.5633,285 shs1.09 million shsMRNSMarinus Pharmaceuticals$0.55-0.2%$0.55$0.22▼$1.97$30.32M1.031.94 million shs260 shsSPYSPDR S&P 500 ETF Trust$660.91+0.5%$638.01$481.80▼$661.04$685.35B169.26 million shs63.60 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMPXAmprius Technologies0.00%+14.19%+14.60%+97.37%+810.44%IWCiShares Micro-Cap ETF0.00%+1.64%+6.29%+17.43%+18.52%LODEComstock0.00%+22.27%+24.89%-27.07%-8.63%MRNSMarinus Pharmaceuticals0.00%0.00%0.00%0.00%-63.39%SPYSPDR S&P 500 ETF Trust0.00%+1.57%+2.17%+9.08%+16.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMPXAmprius Technologies 3.11Buy$11.7139.49% UpsideIWCiShares Micro-Cap ETF 2.98Moderate Buy$146.78N/ALODEComstock 2.00Hold$4.0039.37% UpsideMRNSMarinus Pharmaceuticals 2.44Hold$3.92613.29% UpsideSPYSPDR S&P 500 ETF Trust 2.82Moderate Buy$660.91N/ACurrent Analyst Ratings BreakdownLatest IWC, SPY, AMPX, MRNS, and LODE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025LODEComstockLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral$12.00 ➝ $4.008/8/2025AMPXAmprius TechnologiesCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$10.00 ➝ $12.008/8/2025AMPXAmprius TechnologiesB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$10.00 ➝ $11.008/8/2025AMPXAmprius TechnologiesHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.00 ➝ $18.008/5/2025AMPXAmprius TechnologiesRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$6.00 ➝ $10.007/29/2025LODEComstockLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$12.007/18/2025AMPXAmprius TechnologiesWilliam BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform7/10/2025AMPXAmprius TechnologiesB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$6.00 ➝ $10.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMPXAmprius Technologies$24.17M43.46N/AN/A$0.59 per share14.23IWCiShares Micro-Cap ETFN/AN/AN/AN/AN/AN/ALODEComstock$3.28M31.43N/AN/A$0.68 per share4.22MRNSMarinus Pharmaceuticals$30.99M0.98N/AN/A$0.31 per share1.77SPYSPDR S&P 500 ETF TrustN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMPXAmprius Technologies-$44.67M-$0.33N/AN/AN/A-84.77%-55.79%-32.57%11/6/2025 (Estimated)IWCiShares Micro-Cap ETFN/AN/A15.35∞N/AN/AN/AN/AN/ALODEComstock$9.16M-$1.20N/AN/AN/A-1,210.13%-33.56%-23.62%N/AMRNSMarinus Pharmaceuticals-$141.40M-$2.47N/AN/AN/A-446.48%-7,831.35%-120.74%N/ASPYSPDR S&P 500 ETF TrustN/AN/A25.94∞N/AN/AN/AN/AN/ALatest IWC, SPY, AMPX, MRNS, and LODE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025AMPXAmprius Technologies-$0.08-$0.05+$0.03-$0.05$12.38 million$15.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMPXAmprius TechnologiesN/AN/AN/AN/AN/AIWCiShares Micro-Cap ETF$1.390.95%N/AN/AN/ALODEComstockN/AN/AN/AN/AN/AMRNSMarinus PharmaceuticalsN/AN/AN/AN/AN/ASPYSPDR S&P 500 ETF Trust$7.161.08%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMPXAmprius TechnologiesN/A5.955.59IWCiShares Micro-Cap ETFN/AN/AN/ALODEComstock0.162.452.45MRNSMarinus PharmaceuticalsN/A1.661.47SPYSPDR S&P 500 ETF TrustN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMPXAmprius Technologies5.04%IWCiShares Micro-Cap ETFN/ALODEComstock7.96%MRNSMarinus Pharmaceuticals98.80%SPYSPDR S&P 500 ETF Trust63.54%Insider OwnershipCompanyInsider OwnershipAMPXAmprius Technologies12.80%IWCiShares Micro-Cap ETFN/ALODEComstock4.50%MRNSMarinus Pharmaceuticals5.46%SPYSPDR S&P 500 ETF TrustN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMPXAmprius Technologies50125.08 million109.07 millionOptionableIWCiShares Micro-Cap ETFN/A6.40 millionN/ANot OptionableLODEComstock3035.93 million215.10 millionOptionableMRNSMarinus Pharmaceuticals11055.22 million52.20 millionOptionableSPYSPDR S&P 500 ETF TrustN/A1.04 billionN/ANot OptionableIWC, SPY, AMPX, MRNS, and LODE HeadlinesRecent News About These CompaniesWorld Markets Watchlist: September 15, 2025September 15 at 5:19 PM | etftrends.comETech Buying Pushes S&P 500, Nasdaq to New RecordsSeptember 15 at 4:41 PM | wsj.comNewmont's Midas Touch: Turning Dirt Into 106% YTD Gold While S&P 500 Settles For BronzeSeptember 15 at 2:45 PM | benzinga.comMoving Pieces Ahead of Fed Rate DecisionSeptember 15 at 11:20 AM | zacks.comNASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Continues to Grind HigherSeptember 15 at 9:54 AM | fxempire.comFS&P 500 gains expected as Fed week begins but Nvidia weighsSeptember 15 at 8:21 AM | proactiveinvestors.comSPY ETF News, 9/15/2025September 15 at 7:51 AM | tipranks.comAnalysts Boost S&P 500 Target: ETFs in FocusSeptember 15 at 7:01 AM | zacks.comSPDR S&P 500 ETF Trust Faces Fund Outflows Despite PerformanceSeptember 13 at 12:30 PM | tipranks.comS&P 500 Snapshot: 4-Day Win Streak SnappedSeptember 12 at 6:32 PM | etftrends.comEThis S&P 500 ETF Was the 2nd Most Shorted Security in AugustSeptember 12 at 6:12 PM | investing.comWall Street Rushes to Boost S&P 500 Targets. The Runaway AI Train Keeps Rolling Along.September 12 at 1:27 PM | barrons.comStock Market On Top of the World Ahead of Fed MeetingSeptember 12 at 11:16 AM | zacks.comNASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Quiet in PremarketSeptember 12 at 9:35 AM | fxempire.comFSPY ETF News, 9/12/2025September 12 at 7:31 AM | tipranks.comTwo Big Banks Just Raised Their S&P 500 Targets. Here's Why.September 11, 2025 | investopedia.comNasdaq, S&P 500 set to head to fresh records as Wall Street awaits CPI reportSeptember 11, 2025 | proactiveinvestors.comNASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Creep Slightly HigherSeptember 11, 2025 | fxempire.comFSPY ETF News, 9/11/2025September 11, 2025 | tipranks.comShould SPDR S&P 500 ETF (SPY) Be on Your Investing Radar?September 11, 2025 | zacks.comSilver and Gold Break Out—3 Names to Ride the Wave (SPY)...September 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTop 5 September Stock Picks: Market Tailwinds Drive New MomentumBy Thomas Hughes | September 1, 2025What to Expect From the Q3 Reporting SeasonBy Thomas Hughes | September 3, 2025Equal Weight ETFs: Hidden Upside in Today’s MarketBy Gabriel Osorio-Mazilli | August 23, 2025What August Labor Data Means for the S&P 500 in SeptemberBy Thomas Hughes | September 8, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025IWC, SPY, AMPX, MRNS, and LODE Company DescriptionsAmprius Technologies NYSE:AMPX$8.40 +0.27 (+3.30%) Closing price 03:59 PM EasternExtended Trading$8.41 +0.01 (+0.14%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amprius Technologies, Inc. produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. The company was incorporated in 2008 and is headquartered in Fremont, California.iShares Micro-Cap ETF NYSEARCA:IWC$146.78 +1.01 (+0.69%) Closing price 04:10 PM EasternExtended Trading$146.49 -0.29 (-0.20%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares Micro-Cap ETF, formerly iShares Russell Microcap Index Fund, is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Russell Microcap Index (the Index). The Index measures the microcap sector of the United States equity market. The Index is a float-adjusted capitalization-weighted index and includes equity securities issued by issuers with total market capitalizations ranging from approximately $50 million to $550 million, though these amounts may change from time to time. The Index represents approximately 3% of the market capitalization of listed United States equity securities. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. It invests in a range of sectors, such as financial, health care, technology, producer discretionary, energy and utilities. The Fund's investment advisor is BlackRock Fund Advisors.Comstock NYSE:LODE$2.87 -0.04 (-1.37%) Closing price 04:00 PM EasternExtended Trading$2.96 +0.09 (+3.14%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Comstock Inc. engages in the systemic decarbonization business in Nevada and internationally. It operates through Renewable Energy, Mining, and Strategic and Other Investments segments. It will develop technology for the deploying of extraction and refining facilities that convert wasted and unused biomass and other natural resources; and a demonstration system to extract black mass containing lithium, graphite, nickel, cobalt, manganese, copper, aluminum, and other metals from up to lithium-ion batteries. The company also owns the Lucerne Project located in the Storey County, Nevada; and the Spring Valley Project situated in the Lyon County, Nevada. In addition, it offers upstream and downstream design, engineering, fabrication, procurement, and construction solutions; and invests in non-mining real estate investments. The company was incorporated in 2008 and is based in Virginia City, Nevada.Marinus Pharmaceuticals NASDAQ:MRNSMarinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, and tuberous sclerosis complex. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation and Tenacia Biotechnology (Shanghai) Co., Ltd. Marinus Pharmaceuticals, Inc. was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.SPDR S&P 500 ETF Trust NYSEARCA:SPY$660.91 +3.50 (+0.53%) Closing price 04:10 PM EasternExtended Trading$660.70 -0.20 (-0.03%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
